Publicacions
-
Gomez-Gonzalez S, Garrido- García A, García-Gerique L, Lemos I, Suñol M, de Torres C, Kulis M, Pérez-Jaume S, Carcaboso AM, Luu B, Kieran MW, Jabado N, Kozlenkov A, Dracheva S, Ramaswamy V, Hovestadt V, Johann P, Jones DTW, Pfister SM, Morales-La Madrid A, Cruz-Martínez O, Taylor MD, Martín-Subero JI, Mora J and Lavarino C.
A Novel Method for Rapid Molecular Subgrouping of Medulloblastoma
CLINICAL CANCER RESEARCH . 24(6): 1355-1363. Nº de cites: 22
-
de Rojas T, Bautista F, Ángel Flores Giró, Igual L, Rubio R, Bardón E, Navarro L, Murillo L, Hladun R, Cañete A, Garcia-Ariza M, Garrido C, Fernández-Teijeiro A, Quiroga E, Calvo C, Llort A, de Prada I, Madero L, Cruz-Martínez O and Moreno L.
Management and outcome of children and adolescents with non-medulloblastoma CNS embryonal tumors in Spain: room for improvement in standards of care.
JOURNAL OF NEURO-ONCOLOGY . 137(1): 205-213. Nº de cites: 7
-
Prieto C, López-Millán B, Roca-Ho H, Stam RW, Romero-Moya D, Rodríguez-Baena FJ, Sanjuan-Pla A, Ayllón V, Ramírez M, Bardini M, De Lorenzo P, Valsecchi MG, Stanulla M, Iglesias M, Ballerini P, Carcaboso AM, Mora J, Locatelli F, Bertaina A, Padilla L, Rodríguez-Manzaneque JC, Bueno C and Menéndez P.
NG2 antigen is involved in leukemia invasiveness and central nervous system infiltration in MLL-rearranged infant B-ALL
Leukemia . 32(3): 633-644. Nº de cites: 29
-
Tsoli M, Liu J, Franshaw L, Shen H, Cheng C, Jung M, Joshi S, Ehteda A, Khan A, Carcaboso AM, Dilda PJ, Hogg P and Ziegler DS.
Dual targeting of mitochondrial function and mTOR pathway as a therapeutic strategy for diffuse intrinsic pontine glioma.
Oncotarget . 9(7): 7541-7556. Nº de cites: 27
-
Mack SC, Pajtler KW, Chavez L, Okonechnikov K, Bertrand KC, Wang X, Erkek S, Federation A, Song A, Lee C, Wang X, McDonald L, Morrow JJ, Saiakhova A, Sin-Chan P, Wu Q, Michaelraj KA, Miller TE, Hubert CG, Ryzhova M, Garzia L, Donovan L, Dombrowski S, Factor DC, Luu B, Valentim CLL, Gimple RC, Morton A, Kim L, Prager BC, Lee JJY, Wu X, Zuccaro J, Thompson Y, Holgado BL, Reimand J, Ke SQ, Tropper A, Lai S, Vijayarajah S, Doan S, Mahadev V, Minan AF, Grobner SN, Lienhard M, Zapatka M, Huang Z, Aldape KD, Carcaboso AM, Houghton PJ, Keir ST, Milde T, Witt H, Li Y, Li CJ, Bian XW, Jones DTW, Scott I, Singh SK, Huang A, Dirks PB, Bouffet E, Bradner JE, Ramaswamy V, Jabado N, Rutka JT, Northcott PA, Lupien M, Lichter P, Korshunov A, Scacheri PC, Pfister SM, Kool M, Taylor MD and Rich JN.
Therapeutic targeting of ependymoma as informed by oncogenic enhancer profiling
Nature . 553(7686): 101-105. Nº de cites: 158
-
Chheda ZS, Kohanbash G, Okada K, Jahan N, Sidney J, Pecoraro M, Yang X, Carrera DA, Downey KM, Shrivastav S, Liu S, Lin Y, Lagisetti C, Chuntova P, Watchmaker PB, Mueller S, Pollack IF, Rajalingam R, Carcaboso AM, Mann M, Sette A, Garcia KC, Hou Y and Okada H.
Novel and shared neoantigen derived from histone 3 variant H3.3K27M mutation for glioma T cell therapy
JOURNAL OF EXPERIMENTAL MEDICINE . 215(1): 141-157. Nº de cites: 171
-
Morales-La Madrid A and Kieran MW.
Epigenetics in Clinical Management of Children and Adolescents with Brain Tumors.
CURRENT CANCER DRUG TARGETS . 18(1): 57-64. Nº de cites: 6
-
Howard SC, Davidson A, Luna-Fineman S, Israels T, Chantada G, Lam CG, Hunger SP, Bailey S, Ribeiro RC, Arora RS, Pedrosa F, Harif M and Metzger ML.
A framework to develop adapted treatment regimens to manage pediatric cancer in low- and middle-income countries: The Pediatric Oncology in Developing Countries (PODC) Committee of the International Pediatric Oncology Society (SIOP).
PEDIATRIC BLOOD & CANCER . 64 Suppl 5: . Nº de cites: 54
-
Geoerger B, Bergeron C, Gore L, Sender L, Dunkel IJ, Herzog C, Brochez L, Cruz-Martínez O, Nysom K, Berghorn E, Simsek B, Shen J and Pappo A.
Phase II study of ipilimumab in adolescents with unresectable stage III or IV malignant melanoma.
EUROPEAN JOURNAL OF CANCER . 86: 358-363. Nº de cites: 66
-
Pascual-Pastó G, Gene-Olaciregui N, Opezzo JAW, Castillo-Ecija H, Cuadrado-Vilanova M, Paco-Mercader S, Rivero EM, Vilà-Ubach M, Restrepo-Perdomo CA, Torrebadell-Burriel M, Suñol M, Schaquevich P, Mora J, Bramuglia GF, Chantada G and Carcaboso AM.
Increased delivery of chemotherapy to the vitreous by inhibition of the blood-retinal barrier
JOURNAL OF CONTROLLED RELEASE . 264: 34-44. Nº de cites: 13